As of June 17, 2025, Nexeon Medsystems Inc (NXNN) reports a ROA (Return on Assets) of -10.70%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Nexeon Medsystems Inc's ROA (Return on Assets)
Over recent years, Nexeon Medsystems Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
Date | ROA (Return on Assets) |
---|---|
2019-12-31 | -10.70% |
2018-12-31 | -10.70% |
2017-12-31 | -6.47% |
This fluctuation highlights how Nexeon Medsystems Inc manages its efficiency in using assets to generate earnings over time.
Comparing Nexeon Medsystems Inc's ROA (Return on Assets) to Peers
To better understand Nexeon Medsystems Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
Company | ROA (Return on Assets) |
---|---|
Nexeon Medsystems Inc (NXNN) | -10.70% |
PAVmed Inc (PAVM) | 129.78% |
Hypertension Diagnostics Inc (HDII) | -9.81% |
Remedent Inc (REMI) | -11.43% |
DiaSys Corp (DYXC) | -31.55% |
Paradigm Medical Industries Inc (PDMI) | -36.82% |
Compared to its competitors, Nexeon Medsystems Inc's ROA (Return on Assets) is among the highest compared to peers, demonstrating superior efficiency in generating earnings from assets.